Ownership stake disclosure by WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (amended)
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I, filed by
LFCR
LIFECORE BIOMEDICAL, INC. \DE\ SEC filings
Every EDGAR filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), newest first, with AI summaries and stories.
- Ticker
- LFCR
- CIK
- 1005286
- Sector
- Biotech and pharma
- Latest filing
- Sep 29
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
NOTABLESCHEDULE 13D/ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE NOTABLESCHEDULE 13D/ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Ownership stake disclosure by Legion Partners Asset Management, LLC (amended)
Legion Partners Asset Management, LLC, filed by
ROUTINEDEFA14ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE NOTABLE10-QLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINESCHEDULE 13GLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
NOTABLESCHEDULE 13D/ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Ownership stake disclosure by Legion Partners Asset Management, LLC (amended)
Legion Partners Asset Management, LLC, filed by
ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE NOTABLESCHEDULE 13D/ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Ownership stake disclosure by 22NW Fund, LP (amended)
22NW Fund, LP, filed by
ROUTINE4LIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Christopher S Kiper, insider filing for LFCR
Christopher S Kiper, reporting · Legion Partners Asset Management, LLC, reporting · +5 more
ROUTINE4LIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE 7 insider filings
Nelson Obus, insider filing for LFCR
Show all 7
- 4Insider filing for LFCR
- 4Insider filing for LFCR
- 4Insider filing for LFCR
- 4Insider filing for LFCR
- 4Insider filing for LFCR
- 4Insider filing for LFCR
- 4Insider filing for LFCR
Nelson Obus, reporting
ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE4LIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Paul Josephs, insider filing for LFCR
Paul Josephs, reporting
NOTABLE10-QLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINESCHEDULE 13G/ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINEDEF 14ALIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE4LIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Thomas D. Salus, insider filing for LFCR
Thomas D. Salus, reporting
ROUTINE10-KTLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE4LIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Thomas D. Salus, insider filing for LFCR
Thomas D. Salus, reporting
ROUTINESCHEDULE 13GLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE NOTABLE10-QLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE ROUTINE8-KLIFECORE BIOMEDICAL, INC. \DE\LFCRLIVE